Alpha Teknova (NASDAQ:TKNO – Get Free Report) was upgraded by Zacks Research to a “hold” rating in a note issued to investors on Thursday,Zacks.com reports.
TKNO has been the topic of a number of other research reports. Weiss Ratings restated a “sell (d-)” rating on shares of Alpha Teknova in a research note on Friday, July 17th. Roth Capital started coverage on Alpha Teknova in a research note on Wednesday. They set a “buy” rating and a $7.00 price target on the stock. Finally, Wall Street Zen upgraded Alpha Teknova from a “hold” rating to a “buy” rating in a report on Saturday. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Alpha Teknova presently has an average rating of “Hold” and an average target price of $7.00.
Get Our Latest Stock Report on Alpha Teknova
Alpha Teknova Stock Performance
Alpha Teknova (NASDAQ:TKNO – Get Free Report) last issued its earnings results on Wednesday, August 5th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.02. The business had revenue of $12.19 million for the quarter, compared to analyst estimates of $10.95 million. Alpha Teknova had a negative net margin of 38.37% and a negative return on equity of 24.38%. On average, equities analysts forecast that Alpha Teknova will post -0.32 earnings per share for the current year.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the business. Roubaix Capital LLC raised its stake in shares of Alpha Teknova by 88.5% in the first quarter. Roubaix Capital LLC now owns 1,882,355 shares of the company’s stock worth $5,440,000 after purchasing an additional 883,823 shares during the last quarter. BlackRock Inc. purchased a new stake in Alpha Teknova in the 2nd quarter valued at $4,997,000. Royce & Associates LP bought a new position in Alpha Teknova during the 4th quarter valued at $1,116,000. Balyasny Asset Management L.P. lifted its stake in Alpha Teknova by 19.5% during the 2nd quarter. Balyasny Asset Management L.P. now owns 1,000,484 shares of the company’s stock valued at $4,912,000 after acquiring an additional 163,526 shares in the last quarter. Finally, Massar Capital Management LP boosted its holdings in Alpha Teknova by 185.7% during the 2nd quarter. Massar Capital Management LP now owns 200,000 shares of the company’s stock worth $982,000 after acquiring an additional 130,000 shares during the last quarter. 13.81% of the stock is currently owned by institutional investors and hedge funds.
Alpha Teknova Company Profile
Alpha Teknova, Inc (NASDAQ: TKNO) is a life science tools and reagents company that develops, manufactures and distributes proprietary products to support research, drug discovery and biomanufacturing. Its offerings target academic institutions, pharmaceutical and biotechnology firms, and diagnostic developers, with a focus on high-purity reagents and optimized workflows designed to accelerate molecular biology and protein science applications.
The company’s portfolio includes molecular biology reagents, cell culture buffers, in vitro translation kits, custom recombinant proteins, high-throughput screening buffers and other specialized formulations.
Further Reading
- Five stocks we like better than Alpha Teknova
- MarketBeat Week in Review – 08/03 – 08/07
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.
